State of Alaska Department of Revenue’s Agios Pharmaceuticals AGIO Stock Holding History

State of Alaska Department of Revenue’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$185K	Hold	5,000	–	–	﹤0.01%	1663
2026 Q1	$169K	Hold	5,000	–	–	﹤0.01%	1674
2025 Q4	$136K	Buy	+5,000	New	+$175K	﹤0.01%	1729
2019 Q3	–	Sell	-5,900	Closed	-$293K	–	1633
2019 Q2	$293K	Buy	5,900 +30	+0.5%	+$1.6K	﹤0.01%	1320
2019 Q1	$394K	Sell	5,870 -309	-5%	-$18K	0.01%	1182
2018 Q4	$284K	Buy	6,179 +43	+0.7%	+$2.65K	0.01%	1276
2018 Q3	$472K	Buy	6,136 +176	+3%	+$14.2K	0.01%	1144
2018 Q2	$501K	Buy	5,960 +1,470	+33%	+$128K	0.01%	1067
2018 Q1	$366K	Buy	4,490 +1,690	+60%	+$131K	0.01%	1133
2017 Q4	$160K	Buy	+2,800	New	+$176K	﹤0.01%	1376

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SCM

SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

State of Alaska Department of Revenue's AGIO Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 5,000 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

State of Alaska Department of Revenue first reported a position in AGIO in Q4 2017 and has held it in 10 quarters since. The position peaked at $501K in Q2 2018. 121 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

State of Alaska Department of Revenue held 5,000 shares of Agios Pharmaceuticals worth $185K as of Q2 2026.
State of Alaska Department of Revenue left its Agios Pharmaceuticals share count unchanged in Q2 2026.
Agios Pharmaceuticals made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1663 holding.
State of Alaska Department of Revenue first reported a position in Agios Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
State of Alaska Department of Revenue's Agios Pharmaceuticals position peaked at $501K in Q2 2018.
121 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.